Patent · US Active

Pyrazole glucokinase activators

US7935699B2 · kind B2 · utility

4Cited by

0References

21Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Steven Joseph Berthel · Morristown, US
Robert Francis Kester · Verona, US
Douglas E. Murphy · San Diego, US
Thomas Jay Prins · Irvine, US
Frank Ruebsam · Beijing, CN
Ramakanth Sarabu · Towaco, US
Chinh Viet Tran · San Diego, US
Dionisios Vourloumis · San Diego, US

Key dates

Filing date	Jul 19, 2007
Grant date	May 3, 2011
Priority date	—
Expiry date	Apr 5, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are pyrazole glucokinase activators of the formula (I)useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.